Clinical Trial Update: An Open-label Study to Evaluate the Pharmacokinetics and Safety of Bimekizumab in Pediatric Study Participants With Active Juvenile Idiopathic Arthritis Subtypes Enthesitis-related Arthritis (Including Juvenile-onset Ankylosing Spondylitis) and Juvenile Psoriatic Arthritis [Phase 3]

View source ↗

Summary

This is a Phase 3 open-label pharmacokinetics and safety study of bimekizumab in pediatric patients with Enthesitis-related arthritis and Juvenile psoriatic art…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Enthesitis-related Arthritis
• Juvenile Psoriatic Arthritis

Drugs mentioned

• Bimekizumab (bimekizumab)

Snippet

Sponsor: UCB Biopharma SRL | Conditions: Enthesitis-related Arthritis, Juvenile Psoriatic Arthritis | Phase 3 | Status: RECRUITING